6th International Conference on Thrombosis and Hemostasis Issues in Cancer
April 19, 2012 - April 22, 2012 | Seminario Vescovile Beato “Giovanni XXIII”
The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.
Plenary sessions:
- Epidemiology and risk factors of venous thromboembolism
- Genomics and proteomics of the henostatic system in cancer
- Bleeding complications in cancer patients
- Coagulation and cancer progress
- Hematological disorders
- Anticoagulants and cancer
- Platelets and vascualr endothelium
- Prevention and treatment of thrombosis
Presentations
Update on thrombotic risk stratification
Epidemiology and risk factors of venous thromboembolism
Unsuspected PE in cancer patients
Epidemiology and risk factors of venous thromboembolism
Cancer in pregnancy
Epidemiology and risk factors of venous thromboembolism
Rate of venous thromboembolism by cancer type compared to the general population using multiple linked databases
Epidemiology and risk factors of venous thromboembolism
Thromboembolic complications in children with cancer: data from the italian registry of childhood thrombosis (RITI)
Epidemiology and risk factors of venous thromboembolism
Genetic pathways linking hemostasis and cancer
Genomics and proteomics of the hemostatic system in cancer
Platelet CLEC-2 in lymphangiogenesis
Genomics and proteomics of the hemostatic system in cancer
Platelet systems biology and biomarker discovery
Genomics and proteomics of the hemostatic system in cancer
Akt and Ras pathways and modulation of TF expression in glioblastoma
Genomics and proteomics of the hemostatic system in cancer
TrypsinogenIV, a new player in tumor angiogenesi
Genomics and proteomics of the hemostatic system in cancer
Novel functions of TFPI isoforms in breast cancer cells
Genomics and proteomics of the hemostatic system in cancer
Hemostasis, innate immunity and malignancy
Second Simon Karpatkin Memorial Lecture
Side effects of anti-angiogenic drugs
Bleeding complications in cancer patients
Diagnosis and treatment of disseminated intravascular coagulation
Bleeding complications in cancer patients
Transfusion issues in the cancer patient
Bleeding complications in cancer patients
Acquired hemophilias in cancer
Bleeding complications in cancer patients
Bleeding complications in patients with CKD and malignancy during anticoagulant treatment for venous thromboembolism
Bleeding complications in cancer patients
The respective roles of TF isoforms in cancer
Coagulation and cancer progression
Protein C and cancer
Coagulation and cancer progression
Accounting for death as a competing risk in cancer VTE studies
Coagulation and cancer progression
Binding of anti-GRP78 autoantibodies to cell surface GRP78 promotes cancer progression by activating tissue factor procoagulant activity
Coagulation and cancer progression
Studying cell-microenvironment interactions in a microfluidics model of tumor microcirculation
Coagulation and cancer progression
Risk and management of thrombosis in multiple myeloma
Hematological disorders
The role of JAK-2 inhibition
Hematological disorders
Splanchnic vein thrombosis: New risk factors and management
Hematological disorders
CXCL-4 platelet factor 4, heparin-induced thrombocytopenia and cancer
Hematological disorders
New and old anticoagulants in cancer
Anticoagulants and cancer
Guidelines for antithrombotics in cancer patients
Anticoagulants and cancer
Measurement of new oral anticoagulants
Anticoagulants and cancer
LMWH and survival in lung cancer
Anticoagulants and cancer
The effect of aspirin on cancer mortality
Anticoagulants and cancer
The role of thrombomodulin in tumor growth and metastasis
Platelets and vascular endothelium
Endothelial cell activation markers in cancer
Platelets and vascular endothelium
Novel functions of tissue factor in thrombosis and in cancer
Platelets and vascular endothelium
Microparticles in tumor progression
Platelets and vascular endothelium
On the use of anti-platelet drugs to diminish both tumor growth and thrombosis
Platelets and vascular endothelium
Cellular origin and procoagulant activity of tissue factor-exposing microparticles in cancer patients
Platelets and vascular endothelium
Thromboprophylaxis in the surgical cancer patient
Prevention and treatment of thrombosis
Thromboprophylaxis in the non-surgical cancer patient
Prevention and treatment of thrombosis
Treatment of established thrombotic events
Prevention and treatment of thrombosis
Overview of thrombosis and cancer survival
Prevention and treatment of thrombosis
Use of vena cava filters in cancer patients in California
Prevention and treatment of thrombosis
Infos
| Date | April 19, 2012 - April 22, 2012 |
|---|---|
| Program-Link: | http://www.icthic.com/en/conference/scientific-program.aspx |
| Website: | http://www.icthic.com/en/home/home.aspx |
| Location: | Seminario Vescovile Beato “Giovanni XXIII”; |
| Category: | Medicine; |